中性粒细胞/血小板比值联合C反应蛋白对下肢动脉硬化闭塞症患者死亡风险的预测价值

doi:10.3969/j.issn.1006-5725.2025.19.018

Abstract

Abstract:

Objective To investigate the prognostic significance of the neutrophil-to-platelet ratio （NPR） in combination with C-reactive protein （CRP） in patients with lower extremity arteriosclerosis obliterans （ASO）. Methods A retrospective analysis was conducted on the clinical data of 209 patients with lower extremity ASO admitted to the Department of Critical Care Medicine at Zhongshan Hospital Affiliated to Fudan University （Xiamen） between January 2020 and February 2024. Patients were categorized into either the survival group or the death group based on their in-hospital prognosis. The NPR was calculated on the day of ICU admission， as was the level of CRP. Differences in NPR， CRP， and the combination of NPR and CRP between the two groups were then compared. The prognostic value of NPR， CRP， and their combined use for predicting outcomes in patients with lower extremity ASO was evaluated using receiver operating characteristic （ROC） curve analysis. Based on the optimal cutoff value derived from the ROC curve for the combination of NPR and CRP， patients were divided into two groups. Kaplan-Meier survival analysis was subsequently performed to assess differences in survival outcomes between these two groups. Results The levels of NPR， CRP， alanine aminotransferase， aspartate aminotransferase， creatinine， B-type natriuretic peptide， troponin， and procalcitonin， as well as the proportion of patients with kidney disease in the survival group， were significantly lower than those in the death group， and the differences were statistically significant （P < 0.05）. The albumin level in the survival group was significantly higher than that in the death group， with a statistically significant difference （P < 0.05）. Binary logistic regression analysis revealed that NPR， CRP， the combination of NPR and CRP， and the presence of comorbid kidney disease were independent risk factors influencing patient survival prognosis. ROC curve analysis showed that the areas under the curve （AUC） for NPR， CRP， and the combination of NPR and CRP were 0.648， 0.812， and 0.828， respectively. Both CRP and the combination of NPR and CRP demonstrated statistically significant （P < 0.05）. Compared with either NPR or CRP alone， their combined use showed improved predictive performance. Based on the ROC curve for the combination of NPR and CRP， the optimal cutoff value was determined as 0.029 using the maximum Youden Index. Patients were then divided into high and low NPR + CRP groups according to this cutoff. Kaplan-Meier survival analysis revealed that the in-hospital survival rate in the low NPR + CRP group was significantly higher than that in the high NPR + CRP group， and the difference in survival between the two groups was statistically significant （P = 0.001）. Conclusion NPR combined with CRP is associated with the prognosis of patients with lower extremity ASO and may serve as an effective predictive indicator for their clinical outcomes.

Key words: neutrophil-to-platelet, C-reactive protein, arteriosclerosis obliterans of the lower extremities, prognosis

CLC Number:

R543.5

Xuefeng LIN,Ting. HUANG. The predictive value of the neutrophil⁃to⁃platelet ratio combined with C⁃reactive protein for the risk of death in patients with lower extremity arteriosclerosis obliterans[J]. The Journal of Practical Medicine, 2025, 41(19): 3078-3082.

Figures/Tables 5

Tab.1

Baseline data and related indicators of the two groups"

变量	总数（n = 186）	生存组（n = 173）	死亡组（n = 13）	t/Z/χ2值	P值
男性/［例（%）］	123（66.1）	112（64.7）	11（84.6）	1.337	0.247
年龄（x ± s）/岁	77.59 ± 11.70	77.71 ± 11.76	76.08 ± 11.28	0.483	0.630
中性粒细胞数/（×10⁹/L）	6.65（4.40，9.75）	6.60（4.40，9.70）	8.10（4.80，13.65）	-0.975	0.330
淋巴细胞数/（×10⁹/L）	1.30（0.90，1.80）	1.30（0.90，1.80）	1.30（0.80，2.25）	-0.316	0.752
NLR	4.74（2.67，9.73）	4.58（2.61，9.23）	6.85（2.95，15.71）	-1.287	0.198
血小板/（×10⁹/L）	224.50（166.75，283.50）	229.00（170.00，284.00）	195.00（142.50，282.50）	-0.964	0.335
NPR	0.03（0.02，0.05）	0.03（0.02，0.05）	0.04（0.02，0.08）	-1.981	0.045
CRP/（mg/L）	12.00（2.38，47.75）	9.60（2.30，41.05）	66.50（40.20，190.15）	-3.741	< 0.001
单核细胞数/（×10⁹/L）	0.59（0.44，0.81）	0.58（0.44，0.80）	0.81（0.32，1.05）	-0.788	0.431
NMR	10.49（7.79，14.89）	10.48（7.80，14.42）	11.90（7.63，23.49）	-0.865	0.387
白蛋白（x ± s）/（g/L）	34.71 ± 4.96	34.96 ± 4.86	31.38 ± 5.35	2.541	0.012
谷丙转氨酶/（U/L）	13.00（9.00，21.00）	13.00（9.00，19.50）	23.00（10.00，58.50）	-2.046	0.041
谷草转氨酶/（U/L）	18.00（14.00，28.25）	18.00（14.00，24.00）	43.00（18.50，137.00）	-3.754	< 0.001
肌酐/（μmol/L）	82.50（61.00，115.00）	79.00（61.00，108.00）	192.00（67.00，416.50）	-2.180	0.029
BNP/（pg/mL）	610.00（189.50，2741.00）	528.00（182.50，2217.00）	5191.00（998.00，27015.00）	-2.965	0.003
肌钙蛋白/（ng/mL）	0.02（0.01，0.05）	0.02（0.01，0.05）	0.05（0.02，0.37）	-2.442	0.015
降钙素原/（ng/mL）	0.05（0.03，0.15）	0.05（0.03，0.12）	0.32（0.08，3.77）	-3.382	0.001
高血压/［例（%）］	127（68.3）	119（68.8）	8（61.5）	0.054	0.588
冠心病/［例（%）］	40（21.5）	37（21.4）	3（23.1）	0.020	1.000
糖尿病/［例（%）］	76（40.9）	72（41.6）	4（30.8）	0.226	0.635
肾脏病/［例（%）］	33（17.7）	26（15.0）	7（53.8）	9.966	< 0.001

Tab.1

Tab.2

Fig.1

Tab.3

Fig.2

References 24

[1]	LIAN W S， NIE H P， YUAN Y F， et al. Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans［J］. J Invest Surg， 2021， 34（7）：765-770. doi:10.1080/08941939.2019.1690600 doi: 10.1080/08941939.2019.1690600
[2]	SHAO C G， WUREN B T， CHI G Q， et al. Serum inflammatory factors such as MMP-9 are associated with post-percutaneous transluminal angioplastyacute myocardial infarction in coronary heart disease patients complicated by lower extremity arteriosclerosis obliterans［J］. Cell Mol Biol （Noisy-le-grand）， 2023， 69（15）：38-43. doi:10.14715/cmb/2023.69.15.6 doi: 10.14715/cmb/2023.69.15.6
[3]	ARCHANA S M， MARTIN J S， JOSHUA A B， et al. Association between inflammatory biomarkers and all-cause， cardiovascular and cancer-related mortality［J］. CMAJ， 2017， 189（10）： E384-E390. doi:10.1503/cmaj.160313 doi: 10.1503/cmaj.160313
[4]	AMIR A， SEYEDEH B T S， G-M MAJID， et al. Serum C-reactive protein in the prediction of cardiovascular diseases： Overview of the latest clinical studies and public health practice［J］. J Cell Physiol， 2018， 233（11）：8508-8525. doi:10.1002/jcp.26791 doi: 10.1002/jcp.26791
[5]	DONG Y， WANG X， ZHANG L F， et al. High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study［J］. J Epidemiol Community Health， 2019， 73（2）：188-192. doi:10.1136/jech-2018-211433 doi: 10.1136/jech-2018-211433
[6]	IBRAHIM R， TUFAN Ç， YAVUZ K. Endothelin-1 and C Reactive Protein as Potential Biomarkers for Restenosis in Patients with Arteriosclerosis Obliterans［J］. J Invest Surg， 2021， 34（7）：771-772. doi:10.1080/08941939.2019.1693668 doi: 10.1080/08941939.2019.1693668
[7]	MEAGHAN E C， BENJAMIN E T， YOGENDRA K. Inflammation， Infection and Venous Thromboembolism［J］. Circ Res， 2021， 128（12）：2017-2036. doi:10.1161/circresaha.121.318225 doi: 10.1161/circresaha.121.318225
[8]	SEAN M M， ABHISHEK C. The role of platelet mediated thromboinflammation in acute liver injury［J］. Front Immunol， 2022， 13：1037645. doi:10.3389/fimmu.2022.1037645 doi: 10.3389/fimmu.2022.1037645
[9]	LINA B， ESTHER P， GEMMA A， et al. C-Reactive Protein in Atherothrombosis and Angiogenesis［J］. Front Immunol， 2018， 9：430. doi:10.3389/fimmu.2018.00430 doi: 10.3389/fimmu.2018.00430
[10]	YE M， QIAN X， GUO X J， et al. Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predict Severity and Prognosis of Lower Limb Arteriosclerosis Obliterans［J］. Ann Vasc Surg， 2020， 64：221-227. doi:10.1016/j.avsg.2019.09.005 doi: 10.1016/j.avsg.2019.09.005
[11]	SLAVEN P， LASZLO K S， MONIKA K O， et al. Neutrophil to lymphocyte ratio predicts intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke［J］. J Neuroinflammation， 2018， 15（1）：319. doi:10.1186/s12974-018-1359-2 doi: 10.1186/s12974-018-1359-2
[12]	SAFA K， CENAI Z， AARON M G， et al. Association Between Neutrophil-Lymphocyte Ratio and 30-Day Infection and Thrombotic Outcomes After Intraventricular Hemorrhage： A CLEAR III Analysis［J］. Neurocrit Care， 2024， 40（2）：529-537. doi:10.1007/s12028-023-01774-6 doi: 10.1007/s12028-023-01774-6
[13]	IBA T， LEVY J H. Inflammation and thrombosis： Roles of neutrophils， platelets and endothelial cells and their interactions in thrombus formation during sepsis［J］. J Thromb Haemost， 2018， 16（2）：231-241. doi:10.1111/jth.13911 doi: 10.1111/jth.13911
[14]	BRAHM H S， THEJASWINI G， SORA S， et al. Neutrophil interactions with T cells， platelets， endothelial cells， and of course tumor cells［J］. Immunol Rev， 2023， 314（1）：13-35. doi:10.1111/imr.13178 doi: 10.1111/imr.13178
[15]	INGRID S， JING W， ELZBIETA K， et al. Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice［J］. Hepatology， 2015， 62（5）：1593-1605. doi:10.1002/hep.28003 doi: 10.1002/hep.28003
[16]	JAN R， ANDREAS M， ALEXANDER Z. Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation［J］. Front Immunol， 2018， 9：2712. doi:10.3389/fimmu.2018.02712 doi: 10.3389/fimmu.2018.02712
[17]	ZHANG D C， XU C L， DEEPA M， et al. Neutrophils， platelets， and inflammatory pathways at the nexus of sickle cell disease pathophysiology［J］. Blood， 2016， 127（7）：801-809. doi:10.1182/blood-2015-09-618538 doi: 10.1182/blood-2015-09-618538
[18]	CARSTEN D， PETER K， JULIA V， et al. Platelet secretion is crucial to prevent bleeding in the ischemic brain but not in the inflamed skin or lung in mice［J］. Blood， 2017， 129（12）：1702-1706. doi:10.1182/blood-2016-12-750711 doi: 10.1182/blood-2016-12-750711
[19]	JIN P， LI X， CHEN J， et al. Platelet-to-neutrophil ratio is a prognostic marker for 90-days outcome in acute ischemic stroke［J］. J Clin Neurosci， 2019， 63：110-115. doi:10.1016/j.jocn.2019.01.028 doi: 10.1016/j.jocn.2019.01.028
[20]	LIN Y， DAI W， CHEN Y， et al. Neutrophil-to-platelet ratio predicts mortality following percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction［J］. Front Physiol， 2022， 13：1011048. doi:10.3389/fphys.2022.1011048 doi: 10.3389/fphys.2022.1011048
[21]	SOMASCHINI A， CORNARA S， DEMARCHI A， et al. Neutrophil to platelet ratio： A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention［J］. Eur J Prev Cardiol， 2020， 27（19）：2338-2340. doi:10.1177/2047487319894103 doi: 10.1177/2047487319894103
[22]	LIU Y， JIA S D， YAO Y， et al. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention［J］. J Cardiol， 2020， 75（1）：60-65. doi:10.1016/j.jjcc.2019.06.012 doi: 10.1016/j.jjcc.2019.06.012
[23]	MUHAMMED S， CENGIZ B， AYCA G， et al. Prognostic value of C-reactive protein to albumin ratio for long-term outcomes of patients with peripheral arterial disease underwent endovascular treatment［J］. Vascular， 2022， 30（3）：481-489. doi:10.1177/17085381211025172 doi: 10.1177/17085381211025172
[24]	WANG A T， LIU J， LI C G， et al. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease［J］. J Am Heart Assoc， 2017， 6（10）： e005610. doi:10.1161/jaha.117.005610 doi: 10.1161/jaha.117.005610

项目	β	SE	Wald χ²	OR	95%CI	P值
NPR	0.002	0.001	4.120	1.002	1.000 ~ 1.004	0.042
CRP	0.011	0.005	4.557	1.011	1.001 ~ 1.021	0.033
NPR + CRP	0.023	0.010	5.186	1.024	1.003 ~ 1.044	0.023
肾脏病	-2.329	0.919	6.421	0.097	0.016 ~ 0.590	0.011
常量	-2.401	0.748	10.319	0.091	-	0.001

项目	AUC	95%CI	约登指数	截断值	P值
NPR	0.648	0.480 ~ 0.816	0.258	0.032	0.075
CRP	0.812	0.688 ~ 0.936	0.576	27.100	< 0.001
NPR + CRP	0.828	0.721 ~ 0.935	0.462	0.029	< 0.001

The predictive value of the neutrophil⁃to⁃platelet ratio combined with C⁃reactive protein for the risk of death in patients with lower extremity arteriosclerosis obliterans

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 24

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chengyu QIAN,Linsheng WANG,Xingjiang XIONG,Weidong QIAN. Predictive value of serum LDL⁃C and hs⁃CRP combined with carotid ultrasound parameters in patients with suspected coronary heart disease [J]. The Journal of Practical Medicine, 2025, 41(9): 1401-1406.
[2]	Yingdao CHEN,Haining LI,Yuying LI,Qiping ZHANG,Bingsong LIANG,Guohui. LI. The predictive value of serum miR-143-3p and miR-188-5p levels for poor prognosis in patients with acute cerebral infarction after thrombolysis [J]. The Journal of Practical Medicine, 2025, 41(8): 1117-1122.
[3]	Juan SHEN,Yong WANG,Qiuping WANG,Chen. LING. Relationship between the immune status of patients with multiple myeloma and the changes in the levels of detection of peripheral blood RDW-SD， sBCMA， sFLCR and prognosis [J]. The Journal of Practical Medicine, 2025, 41(8): 1161-1166.
[4]	Yin GUO,Haiqing REN,Xiaoyang GUO,Jianghua ZUO,Ting. WANG. Study on the correlation between serum APRIL， PLA2R⁃Ab， and 25⁃（OH） D₃ levels and the severity and prognosis of primary membranous nephropathy [J]. The Journal of Practical Medicine, 2025, 41(8): 1199-1204.
[5]	Weixiang FENG,Juan WANG,Yanbin SONG,Sheliang XUE,Wenhua LI. The long⁃term prognosis of nonparoxysmal atrial fibrillation （NPAF） patients after radiofrequency catheter ablation [J]. The Journal of Practical Medicine, 2025, 41(7): 1036-1043.
[6]	Fuxia ZHENG,Lijun MIAO,Fengxiang HUANG,Shifu HUANG,Zengyan GAO,Ruixia ZHANG,Yong MENG. The correlation between the levels of APC， TXB2， and sB7⁃H3 in peripheral blood of elderly patients with pneumonia and the severity and prognosis of the disease [J]. The Journal of Practical Medicine, 2025, 41(7): 1056-1061.
[7]	Chunmei MA,Zhikang WU,Ke CHEN,Ziyan WANG,Yu WANG,Lian WANG. Effect of pulmonary artery to aorta diameter ratio on prognosis in patients with acute decompensated heart failure [J]. The Journal of Practical Medicine, 2025, 41(7): 960-967.
[8]	Tong DUAN,Qi WU,Hui. LIU. Correlation between iron death⁃related gene expression level and myocardial dysfunction and prognosis in sepsis [J]. The Journal of Practical Medicine, 2025, 41(6): 846-851.
[9]	Zhuolin YAO,Zhen LI,Caihua ZHANG,Mingmei ZHANG,Ruolin JIA,Yuan CAO,Yiping WANG,Yichun. GUAN. Analysis of clinical outcome of IVF/ICSI with dual⁃stimulation protocol in POSEIDON patients with low expected prognosis [J]. The Journal of Practical Medicine, 2025, 41(4): 580-588.
[10]	Shenglei ZHANG,Ruicong TIAN,Jingjing JIN,Fan LU,Meijuan CHENG,Yaling BAI,Jinsheng. XU. To study the relationship between lymphocyte subsets and renal clinicopathological features and prognosis in patients with IgA nephropathy [J]. The Journal of Practical Medicine, 2025, 41(3): 352-357.
[11]	Yiyang ZHAI,Yunyi MA,Junying ZHAI,Hongli NIU,Ying. WANG. The relationship between tumor necrosis factor alpha inducible protein 8 family members 2， cell proliferation nuclear antigen expression levels， and clinical pathological parameters and prognosis in endometrial cancer tissue [J]. The Journal of Practical Medicine, 2025, 41(3): 379-384.
[12]	Danping WANG,Yufeng CAI,Dehua HU,Liang. ZHANG. The role of LncRNA RMST in gastric cancer： Expression levels， diagnostic value， and prognostic implicationssion [J]. The Journal of Practical Medicine, 2025, 41(3): 409-413.
[13]	Yujian CUI,Yuke LI,Sainan ZHU,Shuangling LI,Nan. LI. The association between early peripheral perfusion and acute kidney injury in patients admitted to the intensive care unit following major noncardiac surgery [J]. The Journal of Practical Medicine, 2025, 41(2): 195-201.
[14]	Jinlan GUO,Xiaoning ZHANG,Jiahui JIANG,Tao. YUAN. Expression of ACTN1 in cutaneous squamous cell carcinoma and its correlation with clinicopathological features and prognosis [J]. The Journal of Practical Medicine, 2025, 41(2): 232-237.
[15]	Ke XU,Mingzhe ZHANG,Mingyang WANG,Song. LIU. Correlation between plasma ADAMTS13 level， disease severity and prognosis in patients with endometriosis [J]. The Journal of Practical Medicine, 2025, 41(2): 238-243.